Pages that link to "Q77214850"
Jump to navigation
Jump to search
The following pages link to Long-term follow-up of an EORTC randomized prospective trial comparing intravesical bacille Calmette-Guérin-RIVM and mitomycin C in superficial bladder cancer. EORTC GU Group and the Dutch South East Cooperative Urological Group. European Organisati (Q77214850):
Displaying 28 items.
- Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer (Q24188046) (← links)
- Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer (Q24247924) (← links)
- An overview of the treatment of superficial bladder cancer. Intravesical chemotherapy (Q33851141) (← links)
- Multicentric Study Comparing Intravesical Chemotherapy Alone and With Local Microwave Hyperthermia for Prophylaxis of Recurrence of Superficial Transitional Cell Carcinoma (Q34272640) (← links)
- Intravesical administration of pirarubicin against superficial bladder cancer: Relationship between tumor tissue concentration and exposure time in the bladder or therapeutic effect (Q36230925) (← links)
- High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder (Q36363238) (← links)
- Evaluating the efficacy and safety of intravesical chemotherapies for non-muscle invasive bladder cancer: a network meta-analysis (Q37696178) (← links)
- Intravesical therapy for urothelial carcinoma of the bladder (Q37911278) (← links)
- Subclinical miliary Mycobacterium bovis following BCG immunotherapy for transitional cell carcinoma of the bladder (Q39702013) (← links)
- Two instillations of epirubicin as prophylaxis for recurrence after transurethral resection of Ta and T1 transitional cell bladder cancer: a prospective, randomized controlled study (Q43200928) (← links)
- Validation of prognostic indices using the frailty model (Q43481303) (← links)
- Quality of care in patients with newly diagnosed bladder cancer: a prospective assessment in northern Germany (Q44701036) (← links)
- Bladder cancer: epidemiology, staging and grading, and diagnosis. (Q45247416) (← links)
- Intravesical electromotive drug administration for non-muscle invasive bladder cancer. (Q47997127) (← links)
- Comparison of the EORTC tables and the EAU categories for risk stratification of patients with nonmuscle-invasive bladder cancer. (Q53059593) (← links)
- A rational risk assessment for intravesical recurrence in primary low-grade Ta bladder cancer: A retrospective analysis of 245 cases. (Q55417624) (← links)
- The value of histopathological prognostic factors in superficial bladder cancer (Q57307317) (← links)
- [Urothelial tumors] (Q63966484) (← links)
- Intravesical therapy of superficial bladder cancer (Q73755473) (← links)
- Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies (Q74326968) (← links)
- [Clinical course and mid- and long-term prognosis of superficial bladder tumors] (Q77527998) (← links)
- [Comparison of the effectiveness between long-term instillation of mitomycin C and short-term prophylaxis with MMC or bacille Calmette-Guérin. Study of patients with non-muscle-invasive urothelial cancer of the urinary bladder] (Q80814209) (← links)
- [Intravesical instillations in the elderly subject] (Q82740406) (← links)
- External validation and applicability of the EORTC risk tables for non-muscle-invasive bladder cancer (Q83053056) (← links)
- Transurethral resection of superficial bladder cancer using 5-aminolevulinic acid: are there any long-term benefits? (Q83324122) (← links)
- Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials (Q83961773) (← links)
- Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer (Q91828240) (← links)
- Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Abridged summary of the Cochrane Review (Q97527244) (← links)